Xenon Pharmaceuticals Inc. , a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced that ...

Stifel Nicolaus analyst Tore Svanberg maintained a Buy rating on Astera Labs, Inc. (ALAB – Research Report) today and set a price target of ...

UNLV Rebels men's golfer Caden Fioroni has been named to the 2024-2025 Haskins Award presented by Stifel First Spring Watch List. The announcement was made by t ...

Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Rhythm Pharmaceuticals (RYTM – Research Report) today and set a price target of ...

Ole Miss junior golfer Michael La Sasso has been named to the 2024-2025 Haskins Award presented by Stifel First Spring Watch ...

Q4 2024 Earnings Call Transcript March 6, 2025 Profound Medical Corp. beats earnings expectations. Reported EPS is $-0.2, ...

MongoDB (NASDAQ:MDB – Free Report) had its price target reduced by Stifel Nicolaus from $425.00 to $340.00 in a research ...

Pointfest with 311, the Urge, Toadies, Finger Eleven and Ludo, 12 p.m. May 17, Hollywood Casino Amphitheatre, 14141 Riverport ...

In the big concerto department, violinist Christian Tetzlaff returns for Brahms (Touhill, 10:30 a.m. April 11, 7:30 p.m.

What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...

Investing.com -- Stifel downgraded Vertex (NASDAQ:VRTX), Inc to “Hold” from “Buy” and lowered its price target to $31 from $35, over the company’s investment strategy and valuation.

ST. LOUIS, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for January 31, 2025 in an effort to provide timely information to investors on ...